XTX Topco Ltd purchased a new position in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 3,085 shares of the scientific and technical instruments company's stock, valued at approximately $326,000.
Several other institutional investors also recently modified their holdings of TRNS. Barclays PLC increased its position in Transcat by 7.3% during the 4th quarter. Barclays PLC now owns 16,234 shares of the scientific and technical instruments company's stock valued at $1,717,000 after purchasing an additional 1,104 shares during the period. Neuberger Berman Group LLC lifted its holdings in Transcat by 1.8% in the fourth quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company's stock valued at $92,415,000 after buying an additional 15,723 shares during the period. Bessemer Group Inc. boosted its position in Transcat by 1,692.4% during the fourth quarter. Bessemer Group Inc. now owns 109,608 shares of the scientific and technical instruments company's stock valued at $11,590,000 after acquiring an additional 103,493 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Transcat during the 4th quarter worth about $2,071,000. Finally, ACK Asset Management LLC bought a new position in shares of Transcat in the 4th quarter worth about $4,758,000. Institutional investors own 98.34% of the company's stock.
Transcat Trading Up 0.5 %
TRNS stock traded up $0.37 during midday trading on Tuesday, hitting $81.35. The company had a trading volume of 6,284 shares, compared to its average volume of 74,028. The stock has a market cap of $757.24 million, a price-to-earnings ratio of 43.94 and a beta of 0.67. Transcat, Inc. has a 52 week low of $67.56 and a 52 week high of $147.12. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. The stock's 50 day moving average price is $77.08 and its 200 day moving average price is $93.89.
Transcat (NASDAQ:TRNS - Get Free Report) last announced its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter last year, the business posted $0.56 EPS. As a group, equities research analysts expect that Transcat, Inc. will post 2.3 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
TRNS has been the subject of several research reports. HC Wainwright reduced their target price on Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a research note on Wednesday, January 29th. Northland Securities reissued a "market perform" rating and issued a $85.00 price target (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Oppenheimer downgraded shares of Transcat from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 29th. Finally, StockNews.com cut shares of Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $111.50.
Read Our Latest Research Report on Transcat
Insider Transactions at Transcat
In related news, Director Craig D. Cairns bought 1,200 shares of the firm's stock in a transaction on Friday, January 31st. The stock was acquired at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the purchase, the director now owns 1,910 shares in the company, valued at approximately $147,108.20. This represents a 169.01 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.30% of the company's stock.
Transcat Profile
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Read More

Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.